September 28, 2021

Holographic Health, Inc. – 613874 – 09/10/2021

Delivery Method: Via Overnight Delivery Product: DrugsFood & Beverages Recipient: Recipient Name Theodore Baroody Recipient Title President Holographic Health, Inc. 516 E. Market StreetKingsport, TN 37660United […]
September 28, 2021

Supplement Science Corp. d/b/a Condemned Labz – 613165 – 09/22/2021

Delivery Method: United Parcel Service Product: Drugs Recipient: Recipient Name Mr.Vincent Miletti Recipient Title General Counsel Supplement Science Corp. d/b/a Condemned Labz 2139 East 3rd StreetBrooklyn, […]
September 28, 2021

Blue Poppy Enterprises Inc – 614126 – 08/06/2021

Delivery Method: Overnight Delivery Product: Drugs Recipient: Recipient Name Young Li Recipient Title Owner Blue Poppy Enterprises Inc 4804 SE 69th AvenuePortland, OR 97206United States Issuing […]
September 28, 2021

Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment

Submit Comments by 11/29/2021 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]
September 27, 2021

FDA-ASCO Hematology and Oncology Fellows Day Workshop. – 11/16/2021 – 11/16/2021

On This Page Date: November 16, 2021 Time: 9:00 AM – 3:00 PM ET FDA-ASCO Hematology and Oncology Fellows Day Workshop. The meeting will be held […]
September 26, 2021

Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency

Summary Company Announcement Date: September 25, 2021 FDA Publish Date: September 26, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Loss of potency Company […]
September 24, 2021

News & Events for Human Drugs

Recent New and Generic Drug Approvals 7-day and 14-day reports from [email protected] New Drugs at FDA CDER’s New Molecular Entities and New Therapeutic Biological Products Meetings, […]
September 24, 2021

Notable Approvals | Drugs

Related Information More information about other drug approvals is available at the FDA Newsroom. Content current as of: 09/24/2021 Regulated Product(s)
September 24, 2021

FDA approves add-on drug for ages 10 & up with rare forms of high cholesterol

Action FDA has approved Repatha (evolocumab) injection as an add-on treatment to diet alone or together with certain other therapies for patients aged 10 years and […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0